Skip To Main Content
Dorte Schou Nørøxe on Muck Rack

Dorte Schou Nørøxe

As seen in: Nature, The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dorte Schou

Contact Dorte Schou, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Glioblastoma cells increase expression of notch signaling and synaptic genes within infiltrated brain tissue - Nature Communications

|
By Vilde Øines Pedersen, Dorte Schou Nørøxe, Ulrik Lassen, Dieter Henrik Heiland, Signe Regner Michaelsen
| Nature Verified
Abstract Glioblastoma remains one of the deadliest brain malignancies. First-line therapy consists of maximal surgical tumor resection, accompanied by chemotherapy and radiotherapy. Malignant cells escape surgical resection by migrating into the surrounding healthy brain tissue, where they give rise to the recurrent tumor.
Open in Who Shared Issue with article?

Ultra-low-dose radiation for gastric MALT lymphoma

|
By Peter Meidahl Petersen, Dorte Schou Nørøxe
| The Lancet Verified
Extranodal marginal zone lymphoma (MZL) of mucosa-associated lymphoid tissue (MALT lymphoma) is relatively rare, accounting for 7–8% of all B-cell lymphomas.The stomach is affected in about 35% of the cases. Setting up a proper randomised study in such a small group of patients is unfortunately not feasible. Therefore, small, well conducted trials such as the study by Jillian R Gunther and colleagues in The Lancet Haematologyare very welcome.
Open in Who Shared Issue with article?
See all 2 articles